Editas Medicine's market cap is currently ―. The company's EPS TTM is €; its P/E ratio is ―; Editas Medicine is scheduled to report earnings on May 1, 2024, and the estimated EPS forecast is €-0.59. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Income Statement	-
Total Revenue	$ 5.34M	$ 2.89M	$ 9.85M	$ 6.54M	$ 42.00K
Gross Profit	$ 5.34M	$ 2.89M	$ 9.85M	-	-
EBIT	$ -45.02M	$ -40.29M	$ -49.04M	$ -63.45M	$ -57.52M
EBITDA	$ -46.23M	$ -38.75M	$ -47.49M	$ -61.87M	$ -55.92M
Net Income Common Stockholders	$ -45.02M	$ -40.29M	$ -49.04M	$ -60.74M	$ -55.73M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 349.62M	$ 431.97M	$ 318.44M	$ 344.27M	$ 419.62M
Total Assets	$ 504.65M	$ 541.95M	$ 464.11M	$ 514.32M	$ 531.03M
Total Debt	$ 34.61M	$ 37.19M	$ 37.14M	$ 43.95M	$ 21.30M
Net Debt	$ -315.01M	$ -394.78M	$ -281.30M	$ -300.33M	$ -398.32M
Total Liabilities	$ 144.19M	$ 142.04M	$ 146.63M	$ 153.64M	$ 116.28M
Stockholders Equity	$ 360.46M	$ 399.92M	$ 317.47M	$ 360.68M	$ 414.75M
Cash Flow	-
Free Cash Flow	$ -35.70M	$ -40.04M	$ -37.61M	$ -42.90M	$ -48.62M
Operating Cash Flow	$ -35.46M	$ -38.71M	$ -35.77M	$ -42.27M	$ -48.00M
Investing Cash Flow	$ -102.82M	$ 12.98M	$ 23.27M	$ -27.53M	$ 89.23M
Financing Cash Flow	-	$ 117.53M	-	$ 619.00K	$ 80.00K

Currency in USD

Editas Medicine Earnings and Revenue History

Income Statement >

Editas Medicine Debt to Assets

Balance Sheet >

Editas Medicine Cash Flow

Cash Flow >

Editas Medicine Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing